Literature DB >> 6738316

Inhibition of human lecithin cholesterol acyltransferase by monoterpenes.

R V Cooney, J Nemhauser, R J Morin.   

Abstract

The lecithin-cholesterol acyltransferase activity of human plasma was found to be inhibited by Rowachol, a proprietary mixture of pure monoterpenes. Menthol, the major ingredient in Rowachol (32%), and a number of other monoterpenes were found to inhibit the enzyme independently. Concentrations of monoterpenes required to achieve 50% inhibition were of the same order of magnitude as the cholesterol concentration present in the reaction mixture.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6738316     DOI: 10.1007/BF02534791

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  17 in total

Review 1.  Lecithin: cholesterol acyltransferase. An exercise in comparative biology.

Authors:  J A Glomset
Journal:  Prog Biochem Pharmacol       Date:  1979

2.  Relationship between high density lipoproteins and the rate of in vitro serum cholesterol esterification.

Authors:  L A Soloff; K G Varma
Journal:  Scand J Clin Lab Invest Suppl       Date:  1978

3.  Formation of palmitate esters of monohydric short chain alcohols by swine arterial subcellular fractions.

Authors:  R J Morin; T Ihrig
Journal:  Lipids       Date:  1974-02       Impact factor: 1.880

4.  A rapid radioassay procedure for plasma lecithin-cholesterol acyltransferase.

Authors:  U Piran; R J Morin
Journal:  J Lipid Res       Date:  1979-11       Impact factor: 5.922

5.  Lecithin: cholesterol acyl transfer rate and high density lipoprotein level in coronary artery disease.

Authors:  L Wallentin; B Moberg
Journal:  Atherosclerosis       Date:  1982-02       Impact factor: 5.162

6.  Human plasma lecithin-cholesterol acyltransferase. Characterization of cofactor-dependent phospholipase activity.

Authors:  L Aron; S Jones; C J Fielding
Journal:  J Biol Chem       Date:  1978-10-25       Impact factor: 5.157

7.  High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study.

Authors:  U Goldbourt; J H Medalie
Journal:  Am J Epidemiol       Date:  1979-03       Impact factor: 4.897

8.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

9.  Elevation of serum high density lipoprotein cholesterol by rowachol, a proprietary mixture of six pure monoterpenes.

Authors:  G D Bell; J P Bradshaw; A Burgess; W Ellis; J Hatton; A Middleton; B Middleton; T Orchard; D A White
Journal:  Atherosclerosis       Date:  1980-05       Impact factor: 5.162

10.  Some steroid hormone-like effects of menthol.

Authors:  T D ELDER; S SEGAL; E S MAXWELL; Y J TOPPER
Journal:  Science       Date:  1960-07-22       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.